Molnár, K.; Lőrinczi, B.; Fazakas, C.; Szatmári, I.; Fülöp, F.; Kmetykó, N.; Berkecz, R.; Ilisz, I.; Krizbai, I.A.; Wilhelm, I.;
et al. SZR-104, a Novel Kynurenic Acid Analogue with High Permeability through the Blood–Brain Barrier. Pharmaceutics 2021, 13, 61.
https://doi.org/10.3390/pharmaceutics13010061
AMA Style
Molnár K, Lőrinczi B, Fazakas C, Szatmári I, Fülöp F, Kmetykó N, Berkecz R, Ilisz I, Krizbai IA, Wilhelm I,
et al. SZR-104, a Novel Kynurenic Acid Analogue with High Permeability through the Blood–Brain Barrier. Pharmaceutics. 2021; 13(1):61.
https://doi.org/10.3390/pharmaceutics13010061
Chicago/Turabian Style
Molnár, Kinga, Bálint Lőrinczi, Csilla Fazakas, István Szatmári, Ferenc Fülöp, Noémi Kmetykó, Róbert Berkecz, István Ilisz, István A. Krizbai, Imola Wilhelm,
and et al. 2021. "SZR-104, a Novel Kynurenic Acid Analogue with High Permeability through the Blood–Brain Barrier" Pharmaceutics 13, no. 1: 61.
https://doi.org/10.3390/pharmaceutics13010061
APA Style
Molnár, K., Lőrinczi, B., Fazakas, C., Szatmári, I., Fülöp, F., Kmetykó, N., Berkecz, R., Ilisz, I., Krizbai, I. A., Wilhelm, I., & Vécsei, L.
(2021). SZR-104, a Novel Kynurenic Acid Analogue with High Permeability through the Blood–Brain Barrier. Pharmaceutics, 13(1), 61.
https://doi.org/10.3390/pharmaceutics13010061